Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972096priorityCriticalpatent/ECSP972096A/es
Publication of ECSP972096ApublicationCriticalpatent/ECSP972096A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La presente invención se refiere a las sales matanosulfonato de 5-(2-(4-(1, 2 benzoisotiazol-3-il)-1-peperazinil)etil)-6- farmacéuticas que contienen dichas sales metanosulfonato dihidratadas y a procedimientos de uso de dichas sales metanosulfonato dihidratadas para tratar trastornos psicóticos.
Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения